Indraprastha Medical Corporation Limited (INDRAMEDCO.BO)
INR 499.25
(-0.7%)
INR 499.25
(-0.7%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.11 Billion | 1.44 Billion | 943 Million | 268.1 Million | 864.51 Million | 751.85 Million |
| Net Income | 1.23 Billion | 1.17 Billion | 790.7 Million | 42.9 Million | 481.92 Million | 446.21 Million |
| Depreciation & Amortization | 400.8 Million | 392.7 Million | 349.4 Million | 333.2 Million | 329.69 Million | 297.54 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 554.6 Million | 66.6 Million | -34.5 Million | -22.7 Million | 155.01 Million | 132.93 Million |
| Other non-cash items | 166.1 Million | -186.4 Million | -162.6 Million | -85.3 Million | -102.11 Million | -124.83 Million |
| Investing Cash Flow | -1.7 Billion | -1.07 Billion | -741.1 Million | -190.8 Million | -401.93 Million | -166.99 Million |
| Investments in PPE | -693.9 Million | -445.8 Million | -294.8 Million | -209.6 Million | -409.18 Million | -170.94 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -1.01 Billion | -722.7 Million | -241 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -890.4 Million | 89.4 Million | -205.3 Million | 18.8 Million | 7.25 Million | 3.95 Million |
| Financing Cash Flow | -313.3 Million | -260.4 Million | -33.7 Million | -31.4 Million | -427.44 Million | -441.84 Million |
| Debt repayment | - | - | - | - | -210 Million | -360 Million |
| Dividends payments | -275.4 Million | -228.4 Million | -2.6 Million | -2.45 Million | -178.63 Million | -161.14 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -48.4 Million | -32 Million | -31.1 Million | -29 Million | -38.81 Million | 79.3 Million |
| Accounts receivables | 138.7 Million | -234.9 Million | 29.4 Million | 96.07 Million | 27.57 Million | 83.47 Million |
| Accounts payables | 406.7 Million | 286.1 Million | -281.5 Million | -141.23 Million | 164.97 Million | 41.38 Million |
| Inventory | 9.2 Million | 15.4 Million | -12.5 Million | 33.3 Million | -37.53 Million | 8.08 Million |
| Other working capital | 406.7 Million | - | 230.1 Million | -10.84 Million | - | - |
| Cash at beginning of period | 548 Million | 417.4 Million | 249.2 Million | 203.3 Million | 168.18 Million | 25.16 Million |
| Cash at end of period | 2.24 Billion | 522.6 Million | 417.4 Million | 249.2 Million | 203.32 Million | 168.18 Million |
| Capital Expenditure | -693.9 Million | -445.8 Million | -294.8 Million | -209.6 Million | -409.18 Million | -170.94 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.69 Billion | 105.2 Million | 168.2 Million | 45.9 Million | 35.14 Million | 143.02 Million |
| Free Cash Flow | 1.42 Billion | 998.9 Million | 648.2 Million | 58.5 Million | 455.33 Million | 580.91 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.23 Billion | 294.4 Million | 328.5 Million | 305 Million | 1.17 Billion | 198.4 Million |
| Depreciation & Amortization | 400.8 Million | 100.3 Million | 100.3 Million | 98.1 Million | 392.7 Million | 98.6 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 554.6 Million | - | - | - | 66.6 Million | - |
| Other non-cash items | 166.1 Million | -100.3 Million | -100.3 Million | -98.1 Million | -186.4 Million | -98.6 Million |
| Investing Cash Flow | -1.7 Billion | - | - | - | -1.07 Billion | - |
| Investments in PPE | -693.9 Million | - | - | - | -445.8 Million | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -1.01 Billion | - | - | - | -722.7 Million | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 89.4 Million | - |
| Financing Cash Flow | -313.3 Million | - | - | - | -260.4 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -275.4 Million | - | - | - | -228.4 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | -32 Million | - |
| Accounts receivables | 138.7 Million | - | - | - | -234.9 Million | - |
| Accounts payables | 406.7 Million | - | - | - | 286.1 Million | - |
| Inventory | 9.2 Million | - | - | - | 15.4 Million | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 548 Million | 2.07 Billion | 1.74 Billion | 548 Million | 417.4 Million | 349.6 Million |
| Cash at end of period | 2.24 Billion | 294.4 Million | 2.07 Billion | 305 Million | 522.6 Million | 548 Million |
| Capital Expenditure | -693.9 Million | - | - | - | -445.8 Million | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.69 Billion | -1.77 Billion | 328.5 Million | -243 Million | 105.2 Million | 198.4 Million |
| Free Cash Flow | 1.42 Billion | 294.4 Million | 328.5 Million | 305 Million | 998.9 Million | 198.4 Million |
HOKCY
ERF
PAISALO
ORPEF
CRM
TYRES